Summit-Securities-Group

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-13
Total Holdings
757
Total Value
637246300
Accession Number
0001531593-25-000004
Form Type
13F-HR
Manager Name
Summit-Securities-Group
Data Enrichment
77% identified
583 identified174 unidentified

Holdings

757 positions • $637.2M total value
Manager:
Search and click to pin securities to the top
Page 37 of 38
Terns Pharmaceuticals, Inc.
Shares:184
Value:$508
% of Portfolio:0.0% ($508/$637.2M)
IMMERSION CORP
Shares:65
Value:$493
% of Portfolio:0.0% ($493/$637.2M)
Berry Corp (bry)
Shares:152
Value:$488
% of Portfolio:0.0% ($488/$637.2M)
iTeos Therapeutics, Inc.
Shares:81
Value:$484
% of Portfolio:0.0% ($484/$637.2M)
BEYOND MEAT, INC.
Shares:156
Value:$476
% of Portfolio:0.0% ($476/$637.2M)
IRONWOOD PHARMACEUTICALS INC
Shares:306
Value:$450
% of Portfolio:0.0% ($450/$637.2M)
GARMIN LTD
Shares:2
Value:$434
% of Portfolio:0.0% ($434/$637.2M)
MASCO CORP /DE/
Shares:6
Value:$417
% of Portfolio:0.0% ($417/$637.2M)
ITT INC.
Shares:3
Value:$387
% of Portfolio:0.0% ($387/$637.2M)
Seritage Growth Properties
Shares:100
Value:$323
% of Portfolio:0.0% ($323/$637.2M)
Piedmont Lithium Inc.
Shares:46
Value:$290
% of Portfolio:0.0% ($290/$637.2M)
C4 Therapeutics, Inc.
Shares:155
Value:$248
% of Portfolio:0.0% ($248/$637.2M)
83307B101
Shares:158
Value:$223
% of Portfolio:0.0% ($223/$637.2M)
Editas Medicine, Inc.
Shares:178
Value:$206
% of Portfolio:0.0% ($206/$637.2M)
Evercore Inc.
Shares:1
Value:$200
% of Portfolio:0.0% ($200/$637.2M)
Cardlytics, Inc.
Shares:104
Value:$189
% of Portfolio:0.0% ($189/$637.2M)
PLIANT THERAPEUTICS, INC.
Shares:133
Value:$180
% of Portfolio:0.0% ($180/$637.2M)
SIMON PROPERTY GROUP INC /DE/
Shares:1
Value:$166
% of Portfolio:0.0% ($166/$637.2M)
WEX Inc.
Shares:1
Value:$157
% of Portfolio:0.0% ($157/$637.2M)
CASSAVA SCIENCES INC
Shares:104
Value:$156
% of Portfolio:0.0% ($156/$637.2M)